Goldman Sachs’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.24M | Sell |
295,329
-19,362
| -6% | -$458K | ﹤0.01% | 3346 |
|
|
2025
Q4 | $7.81M | Sell |
314,691
-2,305
| -0.7% | -$61.2K | ﹤0.01% | 3328 |
|
|
2025
Q3 | $8.99M | Buy |
316,996
+120,354
| +61% | +$3.26M | ﹤0.01% | 3064 |
|
|
2025
Q2 | $4.89M | Sell |
196,642
-80,634
| -29% | -$2.27M | ﹤0.01% | 3441 |
|
|
2025
Q1 | $8.6M | Sell |
277,276
-84,884
| -23% | -$2.83M | ﹤0.01% | 2835 |
|
|
2024
Q4 | $11.4M | Buy |
362,160
+103,291
| +40% | +$4.91M | ﹤0.01% | 2659 |
|
|
2024
Q3 | $15M | Buy |
258,869
+104,412
| +68% | +$5.13M | ﹤0.01% | 2316 |
|
|
2024
Q2 | $6.26M | Buy |
154,457
+24,125
| +19% | +$957K | ﹤0.01% | 2950 |
|
|
2024
Q1 | $5.47M | Sell |
130,332
-4,146
| -3% | -$162K | ﹤0.01% | 3007 |
|
|
2023
Q4 | $5.15M | Buy |
134,478
+76,578
| +132% | +$2.55M | ﹤0.01% | 3131 |
|
|
2023
Q3 | $1.79M | Sell |
57,900
-13,646
| -19% | -$471K | ﹤0.01% | 3851 |
|
|
2023
Q2 | $2.26M | Buy |
71,546
+3,167
| +5% | +$109K | ﹤0.01% | 3781 |
|
|
2023
Q1 | $2.49M | Buy |
68,379
+10,332
| +18% | +$362K | ﹤0.01% | 3694 |
|
|
2022
Q4 | $1.72M | Buy |
58,047
+17,095
| +42% | +$550K | ﹤0.01% | 4054 |
|
|
2022
Q3 | $1.6M | Buy |
40,952
+2,979
| +8% | +$136K | ﹤0.01% | 4165 |
|
|
2022
Q2 | $1.47M | Sell |
37,973
-820
| -2% | -$31.2K | ﹤0.01% | 4315 |
|
|
2022
Q1 | $1.88M | Sell |
38,793
-124,638
| -76% | -$6.43M | ﹤0.01% | 4320 |
|
|
2021
Q4 | $12M | Buy |
163,431
+20,006
| +14% | +$1.64M | ﹤0.01% | 2591 |
|
|
2021
Q3 | $13.1M | Buy |
143,425
+54,992
| +62% | +$4.68M | ﹤0.01% | 2457 |
|
|
2021
Q2 | $5.55M | Buy |
88,433
+80,847
| +1,066% | +$2.99M | ﹤0.01% | 3246 |
|
|
2021
Q1 | $206K | Sell |
7,586
-9,267
| -55% | -$223K | ﹤0.01% | 5629 |
|
|
2020
Q4 | $308K | Sell |
16,853
-492
| -3% | -$8.84K | ﹤0.01% | 4871 |
|
|
2020
Q3 | $311K | Sell |
17,345
-818
| -5% | -$14.1K | ﹤0.01% | 4719 |
|
|
2020
Q2 | $300K | Sell |
18,163
-4,005
| -18% | -$63K | ﹤0.01% | 4630 |
|
|
2020
Q1 | $286K | Sell |
22,168
-11,977
| -35% | -$195K | ﹤0.01% | 4540 |
|
|
2019
Q4 | $629K | Sell |
34,145
-130,752
| -79% | -$2.17M | ﹤0.01% | 4372 |
|
|
2019
Q3 | $2.9M | Buy |
+164,897
| New | +$2.82M | ﹤0.01% | 3271 |
|
|
2019
Q1 | – | Sell |
-13,752
| Closed | -$273K | – | 5512 |
|
|
2018
Q4 | $273K | Sell |
13,752
-18,067
| -57% | -$338K | ﹤0.01% | 4682 |
|
|
2018
Q3 | $702K | Buy |
+31,819
| New | +$670K | ﹤0.01% | 4236 |
|
|
2018
Q2 | – | Sell |
-13,219
| Closed | -$211K | – | 6079 |
|
|
2018
Q1 | $211K | Buy |
+13,219
| New | +$274K | ﹤0.01% | 4976 |
|
Other funds holding ASTH
VPM
3C
VCM
6CM
